Vaccine Development Targeting Bacterial Toxins of Superbugs

The rise of superbugs poses a grave danger to public health worldwide due to their resistance to various antibiotics. The development of new antibiotics is struggling to keep up with the emergence of superbugs, leading to a demand for alternative treatments such as vaccines. Ace Therapeutics is a specialized company working on developing engineered phages and vaccines to combat superbugs. We concentrate on vaccine development services that aim to target bacterial toxins from superbugs.

Superbug Bacterial Toxins

Superbug bacteria owe their pathogenicity to bacterial toxins they produce. These toxins perform a critical role in bacterial infections by inflicting harm to the host tissues and evading the host's immune response. There are various types of toxins, such as endotoxins, exotoxins, and enterotoxins. Some prominent examples of bacterial toxins associated with superbugs include Staphylococcus aureus alpha-toxin, Pseudomonas aeruginosa Exotoxin A, and Clostridium difficile Toxin A and B.

Domain organization of C. difficile toxins.Fig. 1 Domain organization of C. difficile toxins. (Davies A H, et al., 2011)

Vaccine Development Services Targeting Superbug Bacterial Toxins

Ace Therapeutics offers vaccine development services that target bacterial toxins of superbugs. We can employ recombinant DNA technology to create vaccines that trigger the immune system's response against the toxins. The process commences with the expression of toxin genes in a suitable system, leading to the production of the toxin protein. The protein is then purified and transformed into a vaccine suitable for inducing immunity against the toxin in patients.

  • Our vaccine development services encompass the entire process, from initial research to manufacturing and preclinical trials.
  • Our expertise in recombinant DNA technology enables us to design and produce safe and effective vaccines.
  • We help identify the specific toxins that cause infection, which includes a detailed understanding of the molecular mechanisms of these toxins and how they work.
  • We make sure to stimulate a strong enough immune response. This includes careful optimization of vaccine formulation and delivery regimens.
  • We help overcome the challenges of vaccine development due to the complexity of toxins and the high variability of different bacterial strains.

Superbug Toxins that Can Be Used in Vaccine Development

The development of vaccines against superbug toxins is within the expertise of Ace Therapeutics. We provide some of the currently discovered toxins that can be used in vaccine development, including,

  • Staphylococcus aureus alpha-toxin
  • Pseudomonas aeruginosa Exotoxin A
  • Clostridium difficile Toxin A and B

Service Advantages

We provide services for the development of vaccines against superbug toxins. We offer vaccine development services tailored to client needs, with fast turnaround times, rigorous quality assurance procedures, and a team of scientists experienced in vaccine development and recombinant DNA technology.

With our expertise in vaccine development and recombinant DNA technology, Ace Therapeutics is well-positioned to develop effective vaccines against superbug bacterial toxins.


  1. Davies A H, et al. Super toxins from a super bug: structure and function of Clostridium difficile toxins. Biochemical Journal, 2011, 436(3): 517-526.
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Get in touch with our team immediately.